文献速递复苏、休克与脓毒症

旁观者性别与患者性别对院外心脏骤停心肺复苏实施的影响

Impact of bystander and patient sex on cardiopulmonary resuscitation provision in out-of-hospital cardiac arrest.
PubMed 文献 · Emerg Med J · 2026-07-21
一句话结论旁观者为女性时实施旁观者心肺复苏的调整比值比低于男性(aOR 0.83,95%CI 0.73–0.95),患者为男性且旁观者为女性时更低(aOR 0.684,95%CI 0.578–0.810)。

该队列研究利用2019年1月至2023年6月全国前瞻性登记数据,纳入经急救医疗服务转运的成年内科病因院外心脏骤停患者6487例。主要结局为按性别分层的旁观者心肺复苏实施率,次要结局为基于调度员辅助心肺复苏实施状态的旁观者心肺复苏率。患者与旁观者性别不同时旁观者心肺复苏率较低(男性患者-男性旁观者85.0% vs 男性患者-女性旁观者79.2%;女性患者-男性旁观者79.5% vs 女性患者-女性旁观者82.1%)。女性旁观者实施旁观者心肺复苏的调整比值比低于男性旁观者(aOR 0.83,95%CI 0.73–0.95),女性旁观者对男性患者实施心肺复苏的调整比值比显著低于男性旁观者(aOR 0.684,95%CI 0.578–0.810),该差异在实施调度员辅助心肺复苏时缩小(未实施调度员辅助心肺复苏 aOR 0.673,95%CI 0.475–0.952 vs 实施调度员辅助心肺复苏 aOR 0.822,95%CI 0.706–0.957)。作者认为调度员辅助心肺复苏可能作为潜在干预措施帮助减轻这一差异。

要点

  • 女性旁观者实施旁观者心肺复苏的调整比值比低于男性旁观者(aOR 0.83,95%CI 0.73–0.95)。
  • 患者为男性且旁观者为女性时,女性旁观者实施心肺复苏的调整比值比显著低于男性旁观者(aOR 0.684,95%CI 0.578–0.810)。
  • 患者与旁观者性别不同时旁观者心肺复苏率较低:男性患者-男性旁观者85.0% vs 男性患者-女性旁观者79.2%;女性患者-男性旁观者79.5% vs 女性患者-女性旁观者82.1%。
  • 实施调度员辅助心肺复苏时,女性旁观者对男性患者实施心肺复苏的调整比值比差异缩小(未实施调度员辅助心肺复苏 aOR 0.673,95%CI 0.475–0.952 vs 实施调度员辅助心肺复苏 aOR 0.822,95%CI 0.706–0.957)。
  • 作者认为调度员辅助心肺复苏可能作为潜在干预措施帮助减轻这一差异。

适用人群与场景

  • 纳入2019年1月至2023年6月全国前瞻性登记数据中经急救医疗服务转运的成年内科病因院外心脏骤停患者,共6487例(中位年龄55岁,IQR 52–64岁;男性旁观者治疗3977例,占61.3%)。

研究设计与关键结果

  • 研究类型为队列研究,使用2019年1月至2023年6月全国前瞻性登记数据,纳入6487例经急救医疗服务转运的成年内科病因院外心脏骤停患者。
  • 主要结局为按性别分层的旁观者心肺复苏实施率:男性患者-男性旁观者85.0% vs 男性患者-女性旁观者79.2%;女性患者-男性旁观者79.5% vs 女性患者-女性旁观者82.1%。
  • 女性旁观者实施旁观者心肺复苏的调整比值比低于男性旁观者(aOR 0.83,95%CI 0.73–0.95)。
  • 女性旁观者对男性患者实施心肺复苏的调整比值比显著低于男性旁观者(aOR 0.684,95%CI 0.578–0.810)。
  • 次要结局为基于调度员辅助心肺复苏实施状态的旁观者心肺复苏率:未实施调度员辅助心肺复苏时女性旁观者对男性患者实施心肺复苏的aOR 0.673(95%CI 0.475–0.952),实施调度员辅助心肺复苏时aOR 0.822(95%CI 0.706–0.957)。

证据类型、等级与局限

  • 证据类型为队列研究,使用全国前瞻性登记数据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为调度员辅助心肺复苏可能作为潜在干预措施帮助减轻女性旁观者对男性患者实施心肺复苏率较低的差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Female patients who experience out-of-hospital cardiac arrest (OHCA) are less likely to receive bystander cardiopulmonary resuscitation (CPR) than male patients. However, the interaction between the patient and the sex of the bystander in CPR provision remains underexplored. Therefore, this study aimed to investigate the interaction between patient and sex of bystander in CPR provision during OHCA and to assess CPR rates based on dispatcher-assisted CPR (DA-CPR) administration status.

METHODS: This cohort study used prospectively collected nationwide registry data between January 2019 and June 2023. Adult patients with medical aetiology of OHCA who were transported by emergency medical services were included. The primary outcome was bystander CPR provision according to sex. The secondary outcome was the provision of bystander CPR based on DA-CPR administration status.

RESULTS: A total of 6487 patients with OHCA were included (median (IQR) age: 55 (52-64) years; male bystanders treated 3977 patients (61.3%)). The bystander CPR rate was lower when the patient and sex of bystander differed (male patient-male bystander, 85.0% vs male patient-female bystander, 79.2%; female patient-male bystander, 79.5% vs female patient-female bystander, 82.1%). Female bystanders were less likely to provide bystander CPR than male bystanders (adjusted OR (aOR): 0.83, 95% CI 0.73 to 0.95). The odds of a female bystander providing CPR to a male patient were significantly lower than those of a male bystander (aOR: 0.684, 95% CI 0.578 to 0.810). This difference was reduced when DA-CPR was administered (without DA-CPR, aOR: 0.673, 95% CI 0.475 to 0.952 vs with DA-CPR, aOR: 0.822, 95% CI 0.706 to 0.957).

CONCLUSION: An interaction between the patient and the sex of bystander was observed, particularly when the patient was a male and the bystander was a female. DA-CPR may serve as a potential intervention to help mitigate this disparity.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Na S, Yoo KH, Oh J, et al. Impact of bystander and patient sex on cardiopulmonary resuscitation provision in out-of-hospital cardiac arrest. Emerg Med J. 2026. PMID: 41916680. doi:10.1136/emermed-2025-215272

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。